Habitual

Habitual delivers digital prediabetes and type 2 diabetes remission programmes.

London, UK—Founded 2019—Website

$2.6MTotal raised

Habitual provides digital programs designed to help patients reverse prediabetes and type 2 diabetes through nutritional strategies and digital therapeutics. The company aims to enable individuals to live medication-free and achieve long-term disease remission.

Founders

Ian Braithwaite

cofounder & CEO

Ian is the co-founder and CEO of Habitual. His background includes clinical emergency medicine at Barts Health NHS Trust and medical direction at Counterweight.

Napala Pratini

cofounder & COO

Napala is the co-founder and chief executive officer at Habitual. She previously worked in strategy at Harrods and Positive Luxury, alongside advising Juniver.

Investors

Seed5 October 2021
$2.3M
AF
Atlantic Food LabsLead
SeedcampFollow-on
M
MMC
OS
Oxford Seed Fund
Seed30 November 2020
£325K
SeedcampLead
MMC Ventures

Funding history

Seed5 October 2021

$2.3M

Habitual raises $2.3m in seed funding led by Atlantic Food Labs to expand diabetes remission programmes.

The seed round was led by Atlantic Food Labs with participation from Seedcamp, MMC, and the Oxford Seed Fund.

Seed30 November 2020

£325K

Habitual secures £325k in seed funding led by Seedcamp to support its public launch.

Seedcamp led the financing round to help fund the digital health startup's public rollout.